Status:
COMPLETED
Artificial Intelligence in Diagnosis of DFNA9
Lead Sponsor:
Jessa Hospital
Conditions:
DFNA9
Sensorineural Hearing Loss
Eligibility:
All Genders
18+ years
Brief Summary
To study the positive predictive value of Audiogene v.4.0 open source online machine learning tool in accurately predicting DFNA9 (DeaFNess autosomal dominant ninth) as top 3 gene loci in a large seri...
Detailed Description
DFNA9 is an autosomal dominant hereditary adult-onset and progressive sensorineural hearing loss which is associated wit vestibular deterioration. Today, artificial intelligence plays an increasing r...
Eligibility Criteria
Inclusion
- at least 18 years
- genetically confirmed c.151 C\>T, p.Pro51Ser variant carrier in COCH gene
- not contra-indication for audiometric testing
Exclusion
- \<18 years
- no carrier status for c.151C\>T, p.Pro51Ser
- no auditory data available
Key Trial Info
Start Date :
February 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 28 2020
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT04331015
Start Date
February 1 2020
End Date
March 28 2020
Last Update
April 3 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Jessa Hospital
Hasselt, Limburg, Belgium, 3500
2
University of Antwerp
Antwerp, Belgium, 2650